Pricing Log in Create free account

CareDx, Inc. (CDNA) vs Veracyte, Inc. (VCYT)

CareDx, Inc. and Veracyte, Inc. are both Diagnostics & Research companies. CareDx, Inc. is the larger, with a market value of $4.0B against $1.9B — 2.1× the size. Veracyte, Inc. trades at the lower P/E: 15.2× against 30.9×. CareDx, Inc. grew revenue faster over the last twelve months: 38.9% against 17.5%. CareDx, Inc. has the higher net margin (25.9% vs 21.8%) and the higher return on invested capital (33.6% vs 4.33%). Across the 20 metrics below, Veracyte, Inc. leads on 14 and CareDx, Inc. on 6.

Valuation

Metric CDNA VCYT Diagnostics & Research median
P/E 30.91 15.16 34.52
P/S 8.06 3.34 4.24
P/B 8.58 1.35 3.42
Price to free cash flow 68.93 11.98 33.51
EV/EBITDA 26.62 11.76 23.44
EV/Sales 7.57 2.51 5.18
Earnings yield 3.24% 6.59% (1.50%)
Free cash flow yield 1.45% 8.34% 0.00%

Profitability

Metric CDNA VCYT Diagnostics & Research median
Gross margin 70.97% 71.98% 48.32%
Operating margin 23.42% 17.08% (5.68%)
Net margin 25.86% 21.80% (4.10%)
Free cash flow margin 12.01% 27.84% 0.00%
Return on equity 33.04% 9.43% 0.00%
Return on assets 23.96% 8.63% (6.05%)
Return on invested capital 33.56% 4.33% 0.00%

Growth

Metric CDNA VCYT Diagnostics & Research median
Revenue growth (TTM) 38.94% 17.50% 8.99%
EPS growth (last fiscal year) (143.01%) 164.52% 20.36%
Revenue growth, 5-year CAGR 14.59% 34.50% 7.30%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CDNA VCYT Diagnostics & Research median
Debt to equity 0.00 0.00 0.01
Current ratio 2.31 5.56 2.27
Net debt to EBITDA 19.49 (5.44) 0.68

Dividend

Metric CDNA VCYT Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric CDNA VCYT Diagnostics & Research median
Market cap 4.01b 1.93b 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack